Gri Bio Inc. has announced an increase in the number of shares available for issuance under its At The Market Offering Agreement with H.C. Wainwright & Co., LLC. The company has filed a prospectus supplement to raise the maximum number of shares of its common stock, with a par value of $0.0001 per share. The new aggregate total of shares available for issuance is valued at up to $1,758,934. This is in addition to shares already sold under the agreement, which have an aggregate gross sales price of approximately $4,546,137. Legal opinions regarding the issuance and sale of these shares have been provided by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。